Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 16701-16750 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06668935
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
N/ARecruiting
800 participants
Started: Oct 24, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor2 locations
NCT06874348
Functional MRI During Resting State in Patients with Eating Disorders
N/ARecruiting
50 participants
Started: Oct 24, 2024 · Completed: Oct 31, 2026
2 conditions2 sponsors2 locations
NCT06741696
Saline At Different Temperatures After 3rd Molar Surgery
NARecruiting
48 participants
Started: Oct 24, 2024 · Completed: Mar 30, 2025
1 condition1 sponsor1 location
NCT06767579
Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation
N/ARecruiting
350 participants
Started: Oct 24, 2024 · Completed: Oct 17, 2028
2 conditions1 sponsor1 location
NCT05771675
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
EARLY_PHASE1Recruiting
90 participants
Started: Oct 24, 2024 · Completed: Jun 30, 2027
2 conditions2 sponsors2 locations
NCT06882889
Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL
NARecruiting
80 participants
Started: Oct 24, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05903131
Uterine Preservation Via Lifestyle Transformation
PHASE2Recruiting
96 participants
Started: Oct 24, 2024 · Completed: Oct 31, 2029
2 conditions2 sponsors3 locations
NCT06975982
Symptoms, Pulmonary Function, Muscle Strength, Exercise Capacity, and Frailty in Esophageal Atresia vs. Healthy Peers
N/ARecruiting
20 participants
Started: Oct 24, 2024 · Completed: Oct 24, 2027
2 conditions1 sponsor1 location
NCT06723990
Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX
N/ARecruiting
60 participants
Started: Oct 24, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06656390
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
202 participants
Started: Oct 24, 2024 · Completed: Apr 22, 2028
2 conditions1 sponsor1 location
NCT06900049
Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy
EARLY_PHASE1Recruiting
12 participants
Started: Oct 24, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06576726
Sensorimotor and Psychosocial Trajectories in Adolescents with Tic Disorder
N/ARecruiting
351 participants
Started: Oct 24, 2024 · Completed: May 31, 2030
2 conditions1 sponsor1 location
NCT06678191
Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting
N/ARecruiting
800 participants
Started: Oct 24, 2024 · Completed: Aug 31, 2027
2 conditions1 sponsor45 locations
NCT06602193
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
PHASE2Recruiting
50 participants
Started: Oct 24, 2024 · Completed: Feb 28, 2028
1 condition2 sponsors16 locations
NCT06731985
The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes.
N/ARecruiting
750 participants
Started: Oct 24, 2024 · Completed: Oct 31, 2026
3 conditions1 sponsor1 location
NCT06611176
Local LevoBupivacaine for Pain Relief After Endoscopic Submucosal Dissection for Esophageal Lesions
NARecruiting
88 participants
Started: Oct 24, 2024 · Completed: Mar 30, 2026
2 conditions1 sponsor3 locations
NCT06616324
Virtual Reality to Reduce Pain and Anxiety During Extracorporeal Shock Wave Lithotripsy
NARecruiting
72 participants
Started: Oct 24, 2024 · Completed: Oct 1, 2025
4 conditions1 sponsor1 location
NCT06362798
Effect of Support for Low-Income Mothers of Preterm Infants
NARecruiting
420 participants
Started: Oct 24, 2024 · Completed: Aug 31, 2028
2 conditions2 sponsors4 locations
NCT06439082
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
PHASE3Recruiting
315 participants
Started: Oct 24, 2024 · Completed: Apr 19, 2030
1 condition1 sponsor12 locations
NCT06517056
Emovi 3D Knee Assessment Device Intervention for Operational Readiness
NARecruiting
180 participants
Started: Oct 24, 2024 · Completed: Oct 31, 2025
2 conditions2 sponsors2 locations
NCT06644118
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
PHASE1Recruiting
58 participants
Started: Oct 23, 2024 · Completed: Oct 31, 2028
1 condition2 sponsors3 locations
NCT06917066
MYLEAD Spanish Prospective Registry
N/ARecruiting
500 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06147414
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
N/ARecruiting
550 participants
Started: Oct 23, 2024 · Completed: May 31, 2027
15 conditions1 sponsor1 location
NCT06522932
PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy
PHASE1Recruiting
32 participants
Started: Oct 23, 2024 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06585306
High-flow Nasal Oxygen Therapy in Obese Patients Undergoing Sedative Gastroscopy
NARecruiting
864 participants
Started: Oct 23, 2024 · Completed: Oct 20, 2025
3 conditions1 sponsor1 location
NCT06657404
"The Modified Pills-in-the-Pocket Strategy"
NARecruiting
328 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2024
1 condition10 sponsors1 location
NCT06555289
Outcomes of Clareon PanOptix in Patients With Prior Myopic Refractive Surgery
N/ARecruiting
40 participants
Started: Oct 23, 2024 · Completed: Sep 1, 2025
1 condition2 sponsors1 location
NCT06333392
Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: a Randomized Controlled Trial
NARecruiting
1,070 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2026
5 conditions5 sponsors4 locations
NCT06671132
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)
PHASE2Recruiting
220 participants
Started: Oct 23, 2024 · Completed: Jan 30, 2026
2 conditions8 sponsors2 locations
NCT06848569
Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
PHASE2Recruiting
73 participants
Started: Oct 23, 2024 · Completed: Oct 23, 2031
1 condition1 sponsor1 location
NCT06357715
"Effectiveness of Neurodynamic Sliding Mobilisation in the Slump Position in Relation to the Perceptible Pain Threshold in Asymptomatic People"
NARecruiting
54 participants
Started: Oct 23, 2024 · Completed: Nov 6, 2026
1 condition1 sponsor1 location
NCT06138873
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
NARecruiting
100 participants
Started: Oct 23, 2024 · Completed: Nov 23, 2027
2 conditions6 sponsors5 locations
NCT06824688
Single-port Versus Multi-port Robotic Surgery for Rectal Cancer
NARecruiting
40 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06718153
Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation
NARecruiting
100 participants
Started: Oct 23, 2024 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06712511
The Effect of Coffee on Energy Expenditure and Caffeine Metabolism
NARecruiting
60 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06682923
MolecuLightDX Measurement Feature Clinical Validation
N/ARecruiting
72 participants
Started: Oct 23, 2024 · Completed: Feb 28, 2025
2 conditions1 sponsor2 locations
NCT06617715
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
PHASE3Recruiting
3,080 participants
Started: Oct 23, 2024 · Completed: Apr 12, 2026
1 condition1 sponsor1 location
NCT06441682
A Safety and Efficacy Study of ARGX-119 in Adult Patients with Amyotrophic Lateral Sclerosis (ALS)
PHASE2Recruiting
60 participants
Started: Oct 23, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor9 locations
NCT04381689
Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants
PHASE3Recruiting
245 participants
Started: Oct 23, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor2 locations
NCT06044922
Heart Rate Variability in Early Prediction of a Noxic Brain Injury After Cardiac Arrest
N/ARecruiting
200 participants
Started: Oct 23, 2024 · Completed: Dec 15, 2027
1 condition1 sponsor5 locations
NCT06518278
Assessing Central Aspects of Pain
N/ARecruiting
250 participants
Started: Oct 23, 2024 · Completed: Oct 31, 2026
4 conditions3 sponsors1 location
NCT06331195
An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH)
NARecruiting
300 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2026
1 condition4 sponsors1 location
NCT06220721
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
NARecruiting
618 participants
Started: Oct 23, 2024 · Completed: Jun 30, 2029
1 condition2 sponsors2 locations
NCT06668545
Investigating CD 71 in Preeclamptic Pregnancies
N/ARecruiting
39 participants
Started: Oct 23, 2024 · Completed: May 5, 2025
2 conditions1 sponsor1 location
NCT07026539
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
PHASE4Recruiting
80 participants
Started: Oct 23, 2024 · Completed: Apr 30, 2028
3 conditions2 sponsors1 location
NCT06551519
A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis
N/ARecruiting
900 participants
Started: Oct 23, 2024 · Completed: Sep 16, 2027
1 condition1 sponsor26 locations
NCT06593431
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
PHASE3Recruiting
80 participants
Started: Oct 23, 2024 · Completed: Jun 29, 2029
2 conditions1 sponsor1 location
NCT06343805
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
PHASE1Recruiting
76 participants
Started: Oct 23, 2024 · Completed: Feb 15, 2027
6 conditions1 sponsor12 locations
NCT06626334
Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma
NARecruiting
75 participants
Started: Oct 23, 2024 · Completed: Aug 31, 2026
2 conditions5 sponsors1 location
NCT06528613
Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.
N/ARecruiting
450 participants
Started: Oct 23, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor6 locations